Evidence map›Paper›PMID 29548342›Full record

ArticleJournal of nanobiotechnology2018

An efficient antimicrobial depot for infectious site-targeted chemo-photothermal therapy.

Menglong Liu, Danfeng He, Tao Yang, Wei Liu, Li Mao, Yang Zhu, Jun Wu, Gaoxing Luo, Jun Deng

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 102 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. SiORSC advances · 2024
    Article
  9. [Application of advanced biomaterials in wound repair].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2024
    Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Trends in Photothermal Nanostructures for Antimicrobial Applications.International journal of molecular sciences · 2023
    Review
  15. Fighting Methicillin-ResistantInternational journal of molecular sciences · 2023
    Review
  16. Nanomedicine: New Frontiers in Fighting Microbial Infections.Nanomaterials (Basel, Switzerland) · 2023
    Review
  17. Article
  18. Advanced materials and technologies for oral diseases.Science and technology of advanced materials · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Menglong LiuInstitute of Burn Research, Southwest Hospital, State Key Lab of Trauma, Burn and Combined Injury, Third Military Medical University (Army Medical University), Chongqing, 400038, China.
Danfeng HeInstitute of Burn Research, Southwest Hospital, State Key Lab of Trauma, Burn and Combined Injury, Third Military Medical University (Army Medical University), Chongqing, 400038, China.
Tao YangInstitute of Burn Research, Southwest Hospital, State Key Lab of Trauma, Burn and Combined Injury, Third Military Medical University (Army Medical University), Chongqing, 400038, China.
Wei LiuInstitute of Burn Research, Southwest Hospital, State Key Lab of Trauma, Burn and Combined Injury, Third Military Medical University (Army Medical University), Chongqing, 400038, China.
Li MaoDepartment of Laboratory Medicine, Southwest Hospital, Third Military Medical University, (Army Medical University), Chongqing, 400038, People's Republic of China.
Yang ZhuDepartments of Bioengineering and Materials Science and Engineering, University of California, Berkeley, CA, 94720, USA.
Jun WuInstitute of Burn Research, Southwest Hospital, State Key Lab of Trauma, Burn and Combined Injury, Third Military Medical University (Army Medical University), Chongqing, 400038, China. editorinchief@burninchina.com.
Gaoxing LuoInstitute of Burn Research, Southwest Hospital, State Key Lab of Trauma, Burn and Combined Injury, Third Military Medical University (Army Medical University), Chongqing, 400038, China. logxw@yahoo.com.
Jun DengInstitute of Burn Research, Southwest Hospital, State Key Lab of Trauma, Burn and Combined Injury, Third Military Medical University (Army Medical University), Chongqing, 400038, China. djun.123@163.com.
Southwest Hospital · CNArmy Medical University · CNThe First Affiliated Hospital, Sun Yat-sen University · CNUniversity of California, Berkeley · US

Funding

Natural Science Foundation of China 51703243Science and Technology Innovation Plan of Southwest Hospital No. SWH2016ZDCX2014Science and Technology Innovation Plan of Southwest Hospital SWH2016JCYB-04Third Military Medical University Foundation Grant No. 2016XPY12
6 · The paper itself

Abstract

backgroundSilver and photothermal therapy (PTT) have been widely used for eradicating the drug-resistant bacteria. However, the risks of excess of silver for humans and the low efficiency of PTT still limit their in vivo therapeutic application. Integration of two distinctive bactericides into one entity is a promising platform to improve the efficiency of antimicrobial agents.

resultsIn this study, a chemo-photothermal therapeutic platform based on polydopamine (PDA)-coated gold nanorods (GNRs) was developed. The PDA coating acquired high Ag

conclusionsOur studies demonstrate that Ag

Indexed as

AbscessAnimalsAnti-Bacterial AgentsCarbocyaninesChitosanEscherichia coliFluorescent DyesGoldHemolysisHumansHydrogen-Ion ConcentrationHyperthermia, InducedIndolesMaleMetal NanoparticlesMethicillin-Resistant Staphylococcus aureusAnti-Bacterial AgentsCarbocyaninesChitosancyanine dye 5Fluorescent DyesGoldIndolespolydopaminePolymersSilverBacterium-specific targetingCharge conversionCombinational chemo-hyperthermia therapyDrug-resistant bacteriapH-sensitive release

Identifiers

PMID29548342
PMCPMC5857115
OpenAlexW2794004858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.